NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 762 filers reported holding NOVARTIS A G in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $236,000 | -6.3% | 2,848 | -16.2% | 0.02% | -11.8% |
| Q1 2017 | $252,000 | -2.3% | 3,398 | -4.9% | 0.02% | -10.5% |
| Q4 2016 | $258,000 | -14.3% | 3,572 | -5.9% | 0.02% | -17.4% |
| Q3 2016 | $301,000 | -25.7% | 3,796 | -23.2% | 0.02% | -30.3% |
| Q2 2016 | $405,000 | -0.2% | 4,941 | -12.3% | 0.03% | -13.2% |
| Q1 2016 | $406,000 | +10.9% | 5,636 | +33.1% | 0.04% | -17.4% |
| Q4 2015 | $366,000 | +14.7% | 4,234 | +21.7% | 0.05% | +24.3% |
| Q3 2015 | $319,000 | +5.6% | 3,479 | +14.0% | 0.04% | +2.8% |
| Q2 2015 | $302,000 | +1.3% | 3,052 | +1.4% | 0.04% | 0.0% |
| Q1 2015 | $298,000 | +9.2% | 3,011 | +1.5% | 0.04% | 0.0% |
| Q4 2014 | $273,000 | -0.4% | 2,966 | +0.4% | 0.04% | -2.7% |
| Q3 2014 | $274,000 | +1.1% | 2,954 | -2.4% | 0.04% | -5.1% |
| Q2 2014 | $271,000 | +14.8% | 3,028 | +2.3% | 0.04% | -11.4% |
| Q1 2014 | $236,000 | 0.0% | 2,959 | +0.4% | 0.04% | +4.8% |
| Q4 2013 | $236,000 | +10.3% | 2,947 | +7.7% | 0.04% | -17.6% |
| Q3 2013 | $214,000 | – | 2,736 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |